SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Aug 7, 2009
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Aug. 7, 2009 · CIK: 0001367083 · Accession: 0000950123-09-032271
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-157776
Referenced dates: July 31, 2009
Letter
United States Securities and Exchange Commission Division of Corporation Finance Oculus Innovative Sciences, Inc. Post-Effective Amendment on Form S-1 File No. 333-157776
Re:
Dear Mr. Kruczek:
I am securities counsel for Oculus Innovative Sciences, Inc. (the “Company”). I enclose for filing under the Securities Act of 1933, as amended, Amendment No. 2 to the Post-Effective Amendment to Form S-1, File No. 333-157776, together with certain exhibits thereto (the “Amendment”).
The Amendment contains revisions that have been made in response to the comment received from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) in their letter dated July 31, 2009.
Set forth below is the Company’s response to the Staff’s comment. The numbering of the response corresponds to the numbering of the comment in the letter from the Staff.
Comment 1.
You may not deregister a transaction that has occurred. In this regard, we note your statement that this amendment seeks to deregister shares sold or transferred by the selling stockholders. Please withdraw this amendment and revise accordingly.
Response 1.
The Company has complied with the Staff’s comment.
If you have further questions or comments, please feel free to contact us. We are happy to cooperate in any way we can.
Regards,
/s/ Amy M. Trombly
Show Raw Text
CORRESP
1
filename1.htm
corresp
August 7, 2009
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Geoffrey Kruczek
Re:
Oculus Innovative Sciences, Inc.
Post-Effective Amendment on Form S-1
File No. 333-157776
Dear Mr. Kruczek:
I am securities counsel for Oculus Innovative Sciences, Inc. (the “Company”). I enclose for filing
under the Securities Act of 1933, as amended, Amendment No. 2 to the Post-Effective Amendment to
Form S-1, File No. 333-157776, together with certain exhibits thereto (the “Amendment”).
The Amendment contains revisions that have been made in response to the comment received from the
staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) in their
letter dated July 31, 2009.
Set forth below is the Company’s response to the Staff’s comment. The numbering of the response
corresponds to the numbering of the comment in the letter from the Staff.
Comment 1.
You may not deregister a transaction that has occurred. In
this regard, we note your statement that this amendment seeks
to deregister shares sold or transferred by the selling
stockholders. Please withdraw this amendment and revise
accordingly.
Response 1.
The Company has complied with the Staff’s comment.
If you have further questions or comments, please feel free to contact us. We are happy to
cooperate in any way we can.
Regards,
/s/ Amy M. Trombly
Amy M. Trombly